“…Another limitation of ASMS is the reagent requirement, with various approaches using 5–10 µM of the target. 6,7,14,35 Conversely, SAMDI-ASMS technology benefits from up to 50-fold less concentration of the analyte, opening avenues to screen previously intractable targets that may suffer from low expression. Lastly, go or no-go decisions rely on the quality of data generated.…”